Fang Lin Selected Research

Stathmin

1/2020	Adenovirus-mediated anti-AEG-1 ScFv expression driven by stathmin promoter inhibits tumor growth in cervical cancer.
7/2014	Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells.
6/2013	AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation.
9/2010	Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway.
1/2008	Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma.
11/2007	Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression.
11/2006	Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells.
5/2004	[Significance of stathmin gene overexpression in osteosarcoma cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fang Lin Research Topics

Disease

41	Neoplasms (Cancer) 01/2022 - 05/2004
12	Infections 06/2022 - 01/2008
9	Carcinoma (Carcinomatosis) 01/2020 - 08/2007
9	Huntington Disease (Huntington's Disease) 01/2013 - 04/2009
8	Breast Neoplasms (Breast Cancer) 08/2020 - 02/2009
7	Myocardial Infarction 01/2022 - 01/2015
7	Inflammation (Inflammations) 01/2021 - 01/2010
6	Wounds and Injuries (Trauma) 06/2022 - 01/2017
6	Sepsis (Septicemia) 01/2022 - 01/2015
6	COVID-19 01/2021 - 01/2020
5	Fibrosis (Cirrhosis) 11/2022 - 07/2013
5	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2013
5	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2008
4	Hypoxia (Hypoxemia) 01/2022 - 11/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 06/2008
4	Carcinogenesis 03/2015 - 01/2008
3	Ischemia 01/2022 - 01/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2013
3	Liver Failure 01/2022 - 07/2010
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2019
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 09/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 04/2008
3	Disease Progression 01/2020 - 07/2013
3	Ovarian Neoplasms (Ovarian Cancer) 06/2018 - 01/2008
3	Osteosarcoma (Osteogenic Sarcoma) 07/2014 - 05/2004
3	Chronic Hepatitis B 03/2013 - 01/2010
2	Hypertrophy 11/2022 - 02/2020
2	Open Fractures (Compound Fracture) 06/2022 - 12/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 01/2021
2	Cysts 01/2022 - 01/2013
2	Infarction (Infarctions) 10/2021 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2021 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2010
2	Insulin Resistance 01/2021 - 01/2018
2	Acute-On-Chronic Liver Failure 01/2021 - 12/2016
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
2	Necrosis 10/2020 - 03/2013
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 12/2011
2	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 03/2011
2	Lung Injury 11/2014 - 03/2013

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2007
12	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2006
10	CytokinesIBA 01/2021 - 01/2008
8	Peptides (Polypeptides)IBA 04/2022 - 03/2011
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2012
8	StathminIBA 01/2020 - 05/2004
7	SurvivinIBA 06/2013 - 11/2006
6	Messenger RNA (mRNA)IBA 08/2020 - 08/2007
6	Biological ProductsIBA 10/2019 - 09/2004
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2014
5	EnzymesIBA 10/2020 - 10/2008
5	polyglutamineIBA 04/2012 - 11/2007
4	MicroRNAs (MicroRNA)IBA 06/2018 - 02/2013
4	Cisplatin (Platino)FDA LinkGeneric 02/2013 - 02/2009
3	Pharmaceutical PreparationsIBA 04/2021 - 01/2013
3	AntibodiesIBA 01/2021 - 08/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2010
3	Long Noncoding RNAIBA 01/2021 - 01/2017
3	Antiviral Agents (Antivirals)IBA 01/2021 - 03/2012
3	Cobra Neurotoxin ProteinsIBA 12/2020 - 12/2016
3	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 07/2016
3	VaccinesIBA 01/2018 - 08/2012
3	Amino Acids FDA Link 08/2012 - 11/2007
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2010 - 05/2004
2	LipidsIBA 01/2022 - 01/2018
2	CalciumIBA 01/2022 - 01/2022
2	ArtesunateIBA 04/2021 - 07/2014
2	carboxymethyl-chitosanIBA 01/2021 - 01/2021
2	Cathepsin LIBA 01/2021 - 08/2019
2	CollagenIBA 01/2021 - 02/2020
2	InterleukinsIBA 01/2021 - 03/2014
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 07/2013
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2020
2	AntigensIBA 01/2021 - 08/2012
2	Monoclonal AntibodiesIBA 01/2021 - 02/2012
2	Cadherins (E-Cadherin)IBA 08/2020 - 03/2009
2	ChemokinesIBA 01/2019 - 03/2014
2	Subunit VaccinesIBA 11/2018 - 01/2018
2	matrigelIBA 06/2018 - 01/2013
2	Indicators and Reagents (Reagents)IBA 06/2018 - 12/2013
2	CholesterolIBA 03/2018 - 07/2016
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 08/2012
2	Protein Isoforms (Isoforms)IBA 01/2017 - 10/2008
2	Complement C5a (Complement 5a)IBA 01/2016 - 03/2013
2	CaspasesIBA 01/2015 - 03/2012
2	Transcription Factors (Transcription Factor)IBA 09/2014 - 08/2013
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 03/2012
2	Hepatitis B Core AntigensIBA 08/2012 - 03/2012
2	Hemagglutinins (Hemagglutinin)IBA 03/2012 - 01/2010
2	Arsenic Trioxide (Trisenox)FDA Link 12/2011 - 09/2010

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2007
7	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
4	Transplantation 01/2022 - 07/2013
2	Debridement 06/2022 - 12/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2016 - 12/2011
2	Immunotherapy 12/2013 - 01/2013